YorkBridge Wealth Partners’s Emergent Biosolutions EBS Stock Holding History

YorkBridge Wealth Partners’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-132	Closed	-$6K	–	301
2019 Q2	$6K	Sell	132 -51	-28%	-$2.44K	﹤0.01%	638
2019 Q1	$9K	Sell	183 -160	-47%	-$9.44K	﹤0.01%	607
2018 Q4	$20K	Sell	343 -116	-25%	-$7.48K	0.01%	460
2018 Q3	$30K	Buy	459 +5	+1%	+$292	0.01%	421
2018 Q2	$23K	Buy	454 +15	+3%	+$782	0.01%	500
2018 Q1	$24K	Buy	+439	New	+$21.9K	0.01%	479

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

YorkBridge Wealth Partners's EBS Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of Emergent Biosolutions (EBS) in Q3 2019, closing a stake of 132 shares — an estimated $6K sold.

YorkBridge Wealth Partners first reported a position in EBS in Q1 2018 and held it in 6 quarters. The position peaked at $30K in Q3 2018. 244 funds tracked by Wall St. Rank hold EBS as of Q3 2019.

YorkBridge Wealth Partners reported no remaining Emergent Biosolutions position as of Q3 2019 after selling out during the quarter.
YorkBridge Wealth Partners sold 132 Emergent Biosolutions shares in Q3 2019, an estimated $6K.
YorkBridge Wealth Partners first reported a position in Emergent Biosolutions in Q1 2018 and held it in 6 quarters.
YorkBridge Wealth Partners's Emergent Biosolutions position peaked at $30K in Q3 2018.
244 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.